Pharmaceutical News

RSS

TSRI scientists develop easy method for synthesizing compounds with potential to treat lung disorders

Chemists at The Scripps Research Institute have developed a broad and strikingly easy method for synthesizing a class of molecules that have demonstrated value as pharmaceuticals.

17 Apr 2017

Study finds depression and SUD to be strongest risk factors for prescription opioid overdose

Individuals suffering from a substance use disorder (SUD) or depression are among those at highest risk for a serious prescription opioid overdose, according to a study published in Pain Medicine.

13 Apr 2017

Aspirin therapy may not provide benefits to people with peripheral vascular disease, study finds

Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found.

13 Apr 2017

Novel non-invasive technique can deliver drugs to the brain via nanoparticles

Delivering life-saving drugs directly to the brain in a safe and effective way is a challenge for medical providers.

12 Apr 2017

Vitamin B supplements can mitigate impact of fine particle pollution on cardiovascular disease

B vitamins can mitigate the impact of fine particle pollution on cardiovascular disease, according to new research conducted at Columbia University's Mailman School of Public Health.

12 Apr 2017

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.

11 Apr 2017

FDA grants approval for first drug to treat adults with tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

11 Apr 2017

Feinstein Institute research may lead to new treatment option for low-grade gliomas

Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers.

11 Apr 2017

Researchers design first light-activated drug for treatment of pain

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug -the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife.

11 Apr 2017

Combination of NSAIDs and gastric protection can lead to inflammation in small intestine

Patients with inflammatory diseases are often prescribed non-steroidal anti-inflammatory drugs. They are also often recommended to use a proton pump inhibitor to protect their stomach.

11 Apr 2017

New model can simplify process of identifying optimal blends for drug cocktails

Drug cocktails such as those for treating cancer, like the alcoholic versions offered at the local bar, are best when the proper ingredients are mixed in the right proportions.

10 Apr 2017

GPs’ advice on secondary prevention medications disregarded by some stroke survivors, study finds

Some stroke survivors say they are disregarding general practitioners' advice on secondary prevention medications, such as statins, with some patients stopping their medication completely, according to a study of an online stroke forum led by Queen Mary University of London.

10 Apr 2017

BMJ Innovations releases first collaborative definition of patient centricity co-created by AstraZeneca

AstraZeneca today announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry.

10 Apr 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

JAPhA articles highlight role of pharmacists in controlling opioid crisis

Pharmacists often face serious challenges when trying to balance the needs of patients with chronic pain and preventing prescription drug misuse, abuse, and overdose.

7 Apr 2017

Scientists discover protein that helps provide better vaccination response

Researchers have discovered a protein they believe would help make vaccinations more effective and provide protection from other diseases such as cancer.

7 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma.

7 Apr 2017

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group

The Galenica Group announced today that it successfully completed the initial public offering (IPO) of Galenica Santé, its leading provider of health, beauty and well-being products and services on the Swiss Stock Exchange (SIX). Following the IPO, Galenica Group becomes Vifor Pharma Group and will be listed on the Swiss Stock Exchange under its new ticker, VIFN. The company has thus taken the final steps toward separating into two independent companies: Vifor Pharma Group and Galenica Santé.

From CSL Ltd 7 Apr 2017

Biomedical engineers develop new method for delivering drugs to specific neurons

Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.

6 Apr 2017

Pharmaceutical News

TSRI scientists develop easy method for synthesizing compounds with potential to treat lung disorders

Study finds depression and SUD to be strongest risk factors for prescription opioid overdose

Aspirin therapy may not provide benefits to people with peripheral vascular disease, study finds

Novel non-invasive technique can deliver drugs to the brain via nanoparticles

Vitamin B supplements can mitigate impact of fine particle pollution on cardiovascular disease

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

FDA grants approval for first drug to treat adults with tardive dyskinesia

Feinstein Institute research may lead to new treatment option for low-grade gliomas

Researchers design first light-activated drug for treatment of pain

Combination of NSAIDs and gastric protection can lead to inflammation in small intestine

New model can simplify process of identifying optimal blends for drug cocktails

GPs’ advice on secondary prevention medications disregarded by some stroke survivors, study finds

BMJ Innovations releases first collaborative definition of patient centricity co-created by AstraZeneca

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

JAPhA articles highlight role of pharmacists in controlling opioid crisis

Scientists discover protein that helps provide better vaccination response

FDA grants approval for two drugs to treat hepatitis C virus in children

Patients with inducible urticaria can benefit from treatment with asthma drug

Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group

Biomedical engineers develop new method for delivering drugs to specific neurons

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News